Fred Hutch & UW Receive $12M from NIH to Investigate Rare Aggressive Skin Cancer

Jake Siegel of Fred Hutch News Service reports that a multidisciplinary research team involving University of Washington and Fred Hutchinson Cancer Research Center received a $12 million grant to study a deadly form of skin cancer known as Merkel cell carcinoma (MCC). This Seattle-based team has already collaborated on MCC research over the decade including the pivotal clinical trial of an immunotherapy drug that transformed treatment for many cancer patients. The principal investigator, Dr. Paul Nghiem, focuses on new ways to prevent and treat skin cancers by studying the systems that control cell division. For example, such systems help prevent cells with damaged DNA from reproducing and, when they malfunction, can impact cells’ chances of becoming cancerous.

Merkel cell carcinoma (MCC), considerably rarer than melanoma, is three times deadlier. The number of cases grows rapidly. The $12 million National Institutes of Health grant (P01) funds three projects including:

Immune responses to cancer-causing virus

This study focuses on how the immune system responds to a virus that can cause MCC.

Lead research/investigator

Dr. David Koelle

Dr. Denise Galloway


Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee